Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG0604)

Y. Kimura, S. Tamura, K. Fujitani, T. Tsuji, J. Matsuyama, S. Iijima, H. Imamura, K. Inoue, K. Kobayashi, Y. Kurokawa, H. Furukawa(2009).Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604). ASCO-GI2010.

Warning: Trying to access array offset on false in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/single.php on line 62